AAAAAA

   
Results: 1-17 |
Results: 17
Three-year results of the Finnish prostate cancer screening trial
Authors: Maattanen, L Auvinen, A Stenman, UH Tammela, T Rannikko, S Aro, J Juusela, H Hakama, M
Citation: L. Maattanen et al., Three-year results of the Finnish prostate cancer screening trial, J NAT CANC, 93(7), 2001, pp. 552-553
Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences
Authors: Ikonen, S Karkkainen, P Kivisaari, L Salo, JO Taari, K Vehmas, T Tervahartiala, P Rannikko, S
Citation: S. Ikonen et al., Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences, EUR RADIOL, 11(2), 2001, pp. 236-241
Prostatic MR imaging - Accuracy in differentiating cancer from other prostatic disorders
Authors: Ikonen, S Kivisaari, L Tervahartiala, P Vehmas, T Taari, K Rannikko, S
Citation: S. Ikonen et al., Prostatic MR imaging - Accuracy in differentiating cancer from other prostatic disorders, ACT RADIOL, 42(4), 2001, pp. 348-354
Optimal timing of post-biopsy MR imaging of the prostate
Authors: Ikonen, S Kivisaari, L Vehmas, T Tervahartiala, P Salo, JO Taari, K Rannikko, S
Citation: S. Ikonen et al., Optimal timing of post-biopsy MR imaging of the prostate, ACT RADIOL, 42(1), 2001, pp. 70-73
Vasovasostomy - A 15-year experience
Authors: Jokelainen, OS Rintala, E Koskimies, AI Rannikko, S
Citation: Os. Jokelainen et al., Vasovasostomy - A 15-year experience, SC J UROL N, 35(2), 2001, pp. 132-135
Prostate cancer screening within a prostate specific antigen range of 3 to3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests
Authors: Makinen, T Tammela, TLJ Hakama, M Stenman, UH Rannikko, S Aro, J Juusela, H Maattanen, L Auvinen, A
Citation: T. Makinen et al., Prostate cancer screening within a prostate specific antigen range of 3 to3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests, J UROL, 166(4), 2001, pp. 1339-1342
Factors influencing patient radiation doses from barium enema examinations
Authors: Vehmas, T Lampinen, JS Mertjarvi, A Rannikko, S
Citation: T. Vehmas et al., Factors influencing patient radiation doses from barium enema examinations, ACT RADIOL, 41(2), 2000, pp. 167-171
Magnetic resonance imaging of prostatic cancer: Does detection vary between high and low gleason score tumors?
Authors: Ikonen, S Karkkainen, P Kivisaari, L Salo, JO Taari, K Vehmas, T Tervahartiala, P Rannikko, S
Citation: S. Ikonen et al., Magnetic resonance imaging of prostatic cancer: Does detection vary between high and low gleason score tumors?, PROSTATE, 43(1), 2000, pp. 43-48
Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network
Authors: Finne, P Finne, R Auvinen, A Juusela, H Aro, J Maattanen, L Hakama, M Rannikko, S Tammela, TLJ Stenman, UH
Citation: P. Finne et al., Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network, UROLOGY, 56(3), 2000, pp. 418-422
Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer
Authors: Finne, P Zhang, WM Auvinen, A Leinonen, J Maattanen, L Rannikko, S Tammela, TLJ Stenman, UH
Citation: P. Finne et al., Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer, J UROL, 164(6), 2000, pp. 1956-1960
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen
Authors: Finne, P Auvinen, A Koistinen, H Zhang, WM Maattanen, L Rannikko, S Tammela, T Seppala, M Hakama, M Stenman, UH
Citation: P. Finne et al., Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen, J CLIN END, 85(8), 2000, pp. 2744-2747
Prostate cancer - The snowball is rolling
Authors: Ruutu, M Salo, J Nordling, S Rannikko, S
Citation: M. Ruutu et al., Prostate cancer - The snowball is rolling, ANN CHIR GY, 88(1), 1999, pp. 5-8
The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium
Authors: Mikkola, A Ruutu, M Aro, J Rannikko, S Salo, J
Citation: A. Mikkola et al., The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium, ANN CHIR GY, 88(1), 1999, pp. 18-21
Holmium : YAG laser for urinary stones
Authors: Taari, K Lehtoranta, K Rannikko, S
Citation: K. Taari et al., Holmium : YAG laser for urinary stones, SC J UROL N, 33(5), 1999, pp. 295-298
Patient specific doses used to analyse the optimum dose delivery in bariumenema examinations
Authors: Lampinen, JS Rannikko, S
Citation: Js. Lampinen et S. Rannikko, Patient specific doses used to analyse the optimum dose delivery in bariumenema examinations, BR J RADIOL, 72(864), 1999, pp. 1185-1195
European randomized study of prostate cancer screening: first-year resultsof the Finnish trial
Authors: Maattanen, L Auvinen, A Stenman, UH Rannikko, S Tammela, T Aro, J Juusela, H Hakama, M
Citation: L. Maattanen et al., European randomized study of prostate cancer screening: first-year resultsof the Finnish trial, BR J CANC, 79(7-8), 1999, pp. 1210-1214
Characterization and immunological determination of the complex between prostate-specific antigen and alpha(2)-macroglobulin
Authors: Zhang, WM Finne, P Leinonen, J Vesalainen, S Nordling, S Rannikko, S Stenman, UH
Citation: Wm. Zhang et al., Characterization and immunological determination of the complex between prostate-specific antigen and alpha(2)-macroglobulin, CLIN CHEM, 44(12), 1998, pp. 2471-2479
Risultati: 1-17 |